Recent advances in mass spectrometry imaging for multiomics application in neurology

Abstract

Mass spectrometry imaging (MSI) has emerged as a powerful tool for multiomics study in neurology. MSI combines the multichannel (m/z) measurement capability of mass spectrometers with a surface sampling process that allows for rapid probing and mapping of the characterized intact proteins, proteolytic digested peptides, released glycans, phospholipids, glycolipids, and small metabolites in brain tissues. The present review is focused on the application of MSI to the study of proteomics, glycomics, peptidomics, metabolomics, and lipidomics in mouse brain tissues. K E Y W O R D Smass spectrometry imaging, mouse brain,

A Picture Worth a Thousand Molecules—Integrative Technologies for Mapping Subcellular Molecular Organization and Plasticity in Developing Circuits

“…By registering genome-wide single-cell sequencing data to sparse spatial transcriptomic reference frames, deep learning computer vision methods predict spatial expression patterns with increased coverage, error reduction, and multiomic integration (Biancalani et al, 2020;Ma et al, 2020). In principle, similar computational strategies could integrate target-specific proteomic datasets with mass spectrometry imaging (MSI; Xu and Li, 2019) or multi-round protein imaging for spatial proteomics.…”

Natural Products, the Fourth Industrial Revolution, and the Quintuple Helix

“…Using this technique, murine brain tumors and other disease-specific metabolite modifications could be detected. 183 Multiple classes of lipids (fatty acids, ceramides, sterols, etc.) were identified using a matrix of silver nanoparticles.…”

“…were identified using a matrix of silver nanoparticles. 184 Metabolomics studies of neurotransmitters, 185,186 various endogenous and exogenous compounds, 183 including 23 metabolites in the purine biosynthesis pathway, have been visualized in mouse brain, 187 illustrating the potential for drug distribution and metabolism studies once matrix interference issues are resolved, The continuing applications of MSI-based metabolomics will promote it as a very important drug discovery and development tool.…”

Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders

“…In addition, a combination of metabolomics and other types of ‘omics’ data should also be explored when searching for insights into disease mechanisms and biomarkers of disease [ 155 ]. Although very relevant for the investigation of disease mechanism, there is still a lack of multi-omics implementation, mainly due to the complexity of data integration, validation, and interpretation [ 184 , 185 ]. The multi-omics approach is an exciting strategy to understand the simultaneous biological mechanisms occurring during a disease.…”